Conceptual thinking

Conceptual thinking can be described as an alteration to the nature and content of one's internal thought stream. This alteration predisposes a user to think thoughts which are no longer primarily comprised of words and linear sentence structures. Instead, thoughts become equally comprised of what feels to be extremely detailed renditions of the innately understandable and internally stored concepts which words exist to label. Essentially, thoughts cease to be spoken by an internal narrator, and are instead “felt” and intuitively understood.

For example, if one were to think of an idea such as a "chair" during this state, one would not so much hear the word as part of an internal thought stream, but would feel the internally stored, pre-linguistic and innately understandable data which comprises the specific concept labelled within one's memory as a "chair". These conceptual thoughts are felt in a comprehensive level of detail that feels as if it is unparalleled within the primarily linguistic thought structure of everyday life. This is occassionally interpreted by those who undergo it as some sort of a "higher level of understanding".

During this experience, conceptual thinking can cause one to feel not just the entirety of a concept's attributed data, but also how a given concept relates with and depends upon other known concepts. This can result in the perception that one can better comprehend the complex interplay between an idea one is contemplating and how it relates to other ideas.

Conceptual thinking often coincides with personal bias suppression and analysis enhancement. It is a very common effect under the influence of common to heavy dosages of hallucinogens such as psychedelics and dissociatives. However, other compounds such as entactogens and cannnabinoids can inconsistently induce this effect under the influence of heavy dosages.


psychoactive substances

Compounds which may cause this effect commonly include:

1P-ETH-LAD, 1P-LSD, 2-Fluorodeschloroketamine, 25B-NBOH, 25B-NBOMe, 25C-NBOH, 25C-NBOMe, 25D-NBOMe, 25I-NBOH, 25I-NBOMe, 25N-NBOMe, 2C-B, 2C-B-FLY, 2C-C, 2C-D, 2C-E, 2C-P, 2C-T-2, 2C-T-7, 3-HO-PCE, 3-HO-PCP, 3-MeO-PCE, 3-MeO-PCMo, 3-MeO-PCP, 3C-E, 4-AcO-DET, 4-AcO-DMT, 4-AcO-MET, 4-AcO-MiPT, 4-HO-DET, 4-HO-DPT, 4-HO-DiPT, 4-HO-EPT, 4-HO-MET, 4-HO-MPT, 4-HO-MiPT, 4-MeO-PCP, 5-MeO-DALT, 5-MeO-DMT, 5-MeO-DiBF, 5-MeO-DiPT, 5-MeO-MiPT, 5F-AKB48, 5F-PB-22, AB-CHMINACA, AB-FUBINACA, AL-LAD, ALD-52, APICA, Allylescaline, Ayahuasca, Bromo-DragonFLY, Bufotenin, Cannabis, DET, DOB, DOC, DOI, DOM, DPT, Deschloroketamine, Dextromethorphan, Diphenidine, ETH-LAD, Ephenidine, Escaline, Ibogaine, JWH-018, JWH-073, Ketamine, LSA, LSD, LSM-775, LSZ, MET, MPT, Mescaline, Methallylescaline, Methoxetamine, Methoxphenidine, MiPT, Mirtazapine, O-PCE, PARGY-LAD, PCE, PCP, PRO-LAD, Proscaline, Psilocin, Psilocybin mushroom, STS-135, THJ-018, THJ-2201, TMA-2, TMA-6, ΑMT, Βk-2C-B


comments

Documentation written by Josie Kins